2025 Annual Shareholders' Meeting Results

21/08/2025 16:29 NZST, MEETING

News Release

STOCK EXCHANGE LISTINGS: NEW ZEALAND (FPH), AUSTRALIA (FPH)

2025 Annual Shareholders’ Meeting Results

Auckland, New Zealand, 21 August 2025 – Fisher & Paykel Healthcare Corporation Limited advises that all resolutions put to the company’s annual shareholders’ meeting held today were passed.

The seven resolutions were:

Resolution 1: To re-elect Neville Mitchell as a Director.

Resolution 2: To re-elect Lewis Gradon as a Director.

Resolution 3: To re-elect Lisa McIntyre as a Director.

Resolution 4: To re-elect Cather Simpson as a Director.

Resolution 5: To elect Mark Cross as a Director.

Resolution 6: To authorise the Directors to fix the fees and expenses of the company’s auditor.

Resolution 7: To approve the grant of discretionary long term variable remuneration instruments to Lewis Gradon as set out in the Notice of Annual Shareholders’ Meeting 2025.

All resolutions were decided by poll. The details of the total number of votes cast online, in person or by proxy on the polls were as follows:

Resolution Votes:

Resolution 1: Re-election of Neville Mitchell as a Director.

For: 429,216,814 (97.36%); Against: 11,652,978 (2.64%); Abstain: 1,299,617

Resolution 2: Re-election of Lewis Gradon as a Director.

For: 441,426,824 (99.97%); Against: 139,173 (0.03%); Abstain: 601,896

Resolution 3: Re-election of Lisa McIntyre as a Director.

For: 430,486,886 (97.37%); Against: 11,642,888 (2.63%); Abstain: 39,635

Resolution 4: Re-election of Cather Simpson as a Director.

For: 441,889,235 (99.95%); Against: 243,087 (0.05%); Abstain: 37,087

Resolution 5: Election of Mark Cross

For: 437,480,939 (98.98%); Against: 4,489,818 (1.02%); Abstain: 198,652

Resolution 6: Approval of auditors' fees and expenses

For: 437,099,574 (99.05%); Against: 4,211,623 (0.95%); Abstain: 858,212

Resolution 7: Grant of discretionary long term variable remuneration instruments to Lewis Gradon

For: 431,000,052 (97.82%); Against: 9,625,215 (2.18%); Abstain: 963,529

About Fisher & Paykel Healthcare

Fisher & Paykel Healthcare is a leading designer, manufacturer and marketer of products and systems for use in acute and chronic respiratory care, surgery and the treatment of obstructive sleep apnea. The company’s products are sold in over 120 countries worldwide. For more information about the company, visit our website www.fphcare.com.

Contacts

Media

Karen Knott

GM Corporate Communications

karen.knott@fphcare.co.nz

+64 (0) 21 713 911

Investors

Dan Adolph

Head of Investor Relations

daniel.adolph@fphcare.co.nz

+64 (0) 22 511 4050

Authorised by Raelene Leonard, General Counsel & Company Secretary.